Biotech Values

[terry hallinan]

Very bad news for cancer patients. An anti-valentine from your gubmint:

Press Release

FOR IMMEDIATE RELEASE
Tuesday, February 14, 2006


FDA Press Office
301-827-6242
NCI Press Office
[phone]
CMS Press Office
[phone]

New Federal Health Initiative to Improve Cancer Therapy
Patients will Benefit from Rapid Development and Delivery of New Cancer Treatments

The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) -- an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation...

http://tinyurl.com/cs25w

Just my own sense of things, of course.

Good things may happen with a more rational path to approval of biomarkers and maybe even drugs.

As it stands now, nothing at all has been more of an impediment to development of new biomarkers than your gubmint in inaction.

JMO.

Best, Terry